Article info
Extended report
Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis
- Juha Risteli, MD, PhD, Professor of Clinical Chemistry, University of Oulu, PO Box 5000, FI-90014 University of Oulu, Finland; juha.risteli{at}oulu.fi
Citation
Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis
Publication history
- Accepted April 15, 2007
- First published May 1, 2007.
Online issue publication
October 12, 2007
Article Versions
- Previous version (1 May 2007).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2007 BMJ Publishing Group Ltd and European League Against Rheumatism